News | May 03, 2024
RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
Global Phase-3 study initiation expected in the second half of 2024
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
